Molteni M - Search Results

1

MiR-146a induction by cyanobacterial lipopolysaccharide antagonist (CyP) mediates endotoxin cross-tolerance.

Molteni M, Bosi A, Saturni V, Rossetti C. Molteni M, et al. Sci Rep. 2018 Jul 27;8(1):11367. doi: 10.1038/s41598-018-29820-w. Sci Rep. 2018. PMID: 30054544 Free PMC article.

2

The Effect of Cyanobacterial LPS Antagonist (CyP) on Cytokines and Micro-RNA Expression Induced by Porphyromonas gingivalis LPS.

Molteni M, Bosi A, Rossetti C. Molteni M, et al. Toxins (Basel). 2018 Jul 16;10(7):290. doi: 10.3390/toxins10070290. Toxins (Basel). 2018. PMID: 30012943 Free PMC article.

3

Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4.

Molteni M, Marabella D, Orlandi C, Rossetti C. Molteni M, et al. Cancer Lett. 2006 Apr 8;235(1):75-83. doi: 10.1016/j.canlet.2005.04.006. Cancer Lett. 2006. PMID: 15922507

4

Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes.

Maio RC, Cosentino M, Rossetti C, Molteni M, Lecchini S, Marino F. Maio RC, et al. Among authors: molteni m. Int Immunopharmacol. 2011 Feb;11(2):194-8. doi: 10.1016/j.intimp.2010.11.017. Epub 2010 Nov 27. Int Immunopharmacol. 2011. PMID: 21115122

5

The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation.

Molteni M, Gemma S, Rossetti C. Molteni M, et al. Mediators Inflamm. 2016;2016:6978936. doi: 10.1155/2016/6978936. Epub 2016 May 18. Mediators Inflamm. 2016. PMID: 27293318 Free PMC article. Review.

6

Natural Products with Toll-Like Receptor 4 Antagonist Activity.

Molteni M, Bosi A, Rossetti C. Molteni M, et al. Int J Inflam. 2018 Mar 1;2018:2859135. doi: 10.1155/2018/2859135. eCollection 2018. Int J Inflam. 2018. PMID: 29686833 Free PMC article. Review.

7

The medicinal leech as a valuable model for better understanding the role of a TLR4-like receptor in the inflammatory process.

Girardello R, Baranzini N, Molteni M, Rossetti C, Tettamanti G, de Eguileor M, Grimaldi A. Girardello R, et al. Among authors: molteni m. Cell Tissue Res. 2019 Aug;377(2):245-257. doi: 10.1007/s00441-019-03010-0. Epub 2019 Mar 27. Cell Tissue Res. 2019. PMID: 30919048

8

Neurodegenerative diseases: The immunological perspective.

Molteni M, Rossetti C. Molteni M, et al. J Neuroimmunol. 2017 Dec 15;313:109-115. doi: 10.1016/j.jneuroim.2017.11.002. Epub 2017 Nov 8. J Neuroimmunol. 2017. PMID: 29153601 Review.

9

A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression.

Macagno A, Molteni M, Rinaldi A, Bertoni F, Lanzavecchia A, Rossetti C, Sallusto F. Macagno A, et al. Among authors: molteni m. J Exp Med. 2006 Jun 12;203(6):1481-92. doi: 10.1084/jem.20060136. Epub 2006 May 22. J Exp Med. 2006. PMID: 16717116 Free PMC article.

10

A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia.

Jemmett K, Macagno A, Molteni M, Heckels JE, Rossetti C, Christodoulides M. Jemmett K, et al. Among authors: molteni m. Infect Immun. 2008 Jul;76(7):3156-63. doi: 10.1128/IAI.00110-08. Epub 2008 Apr 28. Infect Immun. 2008. PMID: 18443097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters